Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1973 Nov;32(6):536–546. doi: 10.1136/ard.32.6.536

Methotrexate therapy in polymyositis.

F C Arnett, J C Whelton, T M Zizic, M B Stevens
PMCID: PMC1006165  PMID: 4760477

Full text

PDF
538

Images in this article

540Image
on p.540
540Image
on p.540
541Image
on p.541
541Image
on p.541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERLIN N. I., RALL D., MEAD J. A., FREIREICH E. J., VANSCOTT E., HERTZ R., LIPSETT M. B. FOLIC ACID ANTAGONIST. EFFECTS ON THE CELL AND THE PATIENT. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. Ann Intern Med. 1963 Dec;59:931–956. doi: 10.7326/0003-4819-59-6-931. [DOI] [PubMed] [Google Scholar]
  2. BUNIM J. J. A broader spectrum of Sjogren's syndrome and its pathogenetic implications. Ann Rheum Dis. 1961 Mar;20:1–10. doi: 10.1136/ard.20.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clarysse A. M., Cathey W. J., Cartwright G. E., Wintrobe M. M. Pulmonary disease complicating intermittent therapy with methotrexate. JAMA. 1969 Sep 22;209(12):1861–1868. [PubMed] [Google Scholar]
  4. Currie S. Destruction of muscle cultures by lymphocytes from cases of polymyositis. Acta Neuropathol. 1970;15(1):11–19. doi: 10.1007/BF00690685. [DOI] [PubMed] [Google Scholar]
  5. Filip D. J., Logue G. L., Harle T. S., Farrar W. H. Pulmonary and hepatic complications of methotrexate therapy of psoriasis. JAMA. 1971 May 3;216(5):881–882. [PubMed] [Google Scholar]
  6. Goldman G. C., Moschella S. L. Severe pneumonitis occurring during methotrexate therapy. Re- port of two cases. Arch Dermatol. 1971 Feb;103(2):194–197. [PubMed] [Google Scholar]
  7. Hersh E. M., Wong V. G., Freireich E. J. Inhibition of the local inflammatory response in man by antimetabolites. Blood. 1966 Jan;27(1):38–48. [PubMed] [Google Scholar]
  8. Malaviya A. N., Many A., Schwartz R. S. Treatment of dermatomyositis with methotrexate. Lancet. 1968 Aug 31;2(7566):485–488. doi: 10.1016/s0140-6736(68)90649-1. [DOI] [PubMed] [Google Scholar]
  9. Mitchell M. S., Wade M. E., DeConti R. C., Bertino J. R., Calabresi P. Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med. 1969 Mar;70(3):535–547. doi: 10.7326/0003-4819-70-3-535. [DOI] [PubMed] [Google Scholar]
  10. PEARSON C. M. Polymyositis and dermatomyositis. Bull Rheum Dis. 1962 Feb;12:269–272. [PubMed] [Google Scholar]
  11. Pasquinucci G., Ferrara P., Castellari R. Daunorubicin treatment of methotrexate pneumonia. JAMA. 1971 Jun 21;216(12):2017–2017. doi: 10.1001/jama.1971.03180380071026. [DOI] [PubMed] [Google Scholar]
  12. Rivarola A., Friedman M., Lawrence W., Jr Methotrexate and the immune response. Transplantation. 1967 Jul;5(4 Suppl):1223–1230. doi: 10.1097/00007890-196707001-00062. [DOI] [PubMed] [Google Scholar]
  13. Robertson J. H. Pneumonia and methotrexate. Br Med J. 1970 Apr 18;2(5702):156–156. doi: 10.1136/bmj.2.5702.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Saunders M., Knowles M., Currie S. Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry. 1969 Dec;32(6):569–571. doi: 10.1136/jnnp.32.6.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schwartz I. R., Kajani M. K. Methotrexate therapy and pulmonary disease. JAMA. 1969 Dec 8;210(10):1924–1924. [PubMed] [Google Scholar]
  16. Sokoloff M. C., Goldberg L. S., Pearson C. M. Treatment of corticosteroid-resistant polymyositis with methotrexate. Lancet. 1971 Jan 2;1(7688):14–16. doi: 10.1016/s0140-6736(71)80005-3. [DOI] [PubMed] [Google Scholar]
  17. Thompson J. M., Bluestone R., Bywaters E. G., Dorling J., Johnson M. Skeletal muscle involvement in systemic sclerosis. Ann Rheum Dis. 1969 May;28(3):281–288. doi: 10.1136/ard.28.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. VIGNOS P. J., Jr, BOWLING G. F., WATKINS M. P. POLYMYOSITIS; EFFECT OF CORTICOSTEROIDS ON FINAL RESULT. Arch Intern Med. 1964 Aug;114:263–277. doi: 10.1001/archinte.1964.03860080113012. [DOI] [PubMed] [Google Scholar]
  19. WHITE W. Lupus erythematosus. Polyositis. Proc R Soc Med. 1959 Dec;52:1035–1036. [PMC free article] [PubMed] [Google Scholar]
  20. WILLIAMS R. C., Jr Dermatomyositis and malignancy: a review of the literature. Ann Intern Med. 1959 May;50(5):1174–1181. doi: 10.7326/0003-4819-50-5-1174. [DOI] [PubMed] [Google Scholar]
  21. Whitaker J. N., Engel W. K. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med. 1972 Feb 17;286(7):333–338. doi: 10.1056/NEJM197202172860701. [DOI] [PubMed] [Google Scholar]
  22. Winkelmann R. K., Mulder D. W., Lambert E. H., Howard F. M., Jr, Diessner G. R. Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients. Mayo Clin Proc. 1968 Aug;43(8):545–556. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES